Gastric Bypass Often a strong option for reflux, diabetes, revision surgery, or selected higher-risk situations
The oral route of administration represents a significant advancement in the field
TB-500 plays crucial roles in cellular migration, tissue remodeling, and inflammation resolution
Data will be shared with bona fide researchers submitting a research proposal and requesting access to data, for use as approved by the Independent Review Board (IRB) according to the IRB Charter (see www.novonordisk-trials.com)
It's important to note that GLP-1 receptor agonists are not licensed for type 1 diabetes or for the treatment of diabetic ketoacidosis, and they are not a substitute for insulin
The scale reflects all of it without distinction